Related references
Note: Only part of the references are listed.Cardiovascular Drug Development
Christopher B. Fordyce et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Peering into the pharmaceutical pipeline: Investigational drugs, clinical trials, and industry priorities
Jill A. Fisher et al.
SOCIAL SCIENCE & MEDICINE (2015)
Economic Return From the Women's Health Initiative Estrogen Plus Progestin Clinical Trial
Joshua A. Roth et al.
ANNALS OF INTERNAL MEDICINE (2014)
Tracking the Pharmaceutical Pipeline: Clinical Trials and Global Disease Burden
Marci D. Cottingham et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Publication of Trials Funded by the National Heart, Lung, and Blood Institute
David Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The ClinicalTrials.gov Results Database - Update and Key Issues
Deborah A. Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Medicine - Moving toward transparency of clinical trials
Deborah A. Zarin et al.
SCIENCE (2008)
Trial registration at ClinicalTrials.Gov between May and October 2005
DA Zarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials
D Moher et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
